| Opella Healthcare Switzerland AG - Buscopan Inject, Injektionslösung |
| 17352 | | 01 | | Buscopan Inject | | Injektionslösung | | A03BB01 | | Butylscopolamine | | 14.06.1952 | | |
|
| Composition |
| scopolamini butylbromidum 20 mg, natrii chloridum, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Scopolamine Butylbromide | 20 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Scopolamine Butylbromide | 20 mg |
| | | | Inactive agents |
|---|
| Sodium Chloride |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 025 | 5 ampoule(s) | 3.06 | 12.55 | B | SL | No |
|
